Profil
Cynthia Seidel-Dugan worked as the Chief Scientific Officer at Potenza Therapeutics, Inc. from 2018 to 2018.
Prior to that, she was the Vice President-Biology at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Currently, she is the Chief Scientific Officer at Werewolf Therapeutics, Inc. from 2019 to 2024.
Dr. Seidel-Dugan holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from The College of William & Mary.
Ehemalige bekannte Positionen von Cynthia Seidel-Dugan
| Unternehmen | Position | Ende |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 29.03.2024 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Corporate Officer/Principal | 01.12.2018 |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Corporate Officer/Principal | 01.02.2014 |
Ausbildung von Cynthia Seidel-Dugan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Develops oncology programs and mechanisms for tumors detection | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The College of William & Mary
The College of William & Mary Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
















